Prokidney (PROK) Net Cash Flow (2021 - 2026)
Prokidney (PROK) reported Net Cash Flow of -$6.6 million for Q1 2026, down 405.1% year-over-year from $2.2 million in Q1 2025, and down 150.26% quarter-over-quarter from $13.2 million in Q4 2025.
Prokidney (PROK) Net Cash Flow (2021 - 2026) Analysis & Trends
Prokidney (PROK) has 6 years of Net Cash Flow data on file, last reported at -$6.6 million in Q1 2026.
- Net Cash Flow for Q1 2026 came in at -$6.6 million, down 405.1% year-over-year; the trailing twelve-month figure through Mar 2026 was $4.1 million (down 69.51% YoY), and the FY2025 annual result was $9.4 million, down 75.52% from the prior year.
- Net Cash Flow declined to -$6.6 million in Q1 2026 per PROK's latest filing, from $13.2 million in the prior quarter.
- Over five years, Net Cash Flow peaked at $484.4 million in Q3 2022 and troughed at -$218.6 million in Q1 2023.
- A 5-year average of $4.8 million and a median of -$7.9 million in 2022 frame the typical range for Net Cash Flow.
- On a YoY basis, Net Cash Flow climbed as much as 89230.89% in 2022 and fell as far as 3749.36% in 2022.
- A 5-year view of Net Cash Flow shows it stood at -$16.1 million in 2022, then sank by 713.31% to -$130.7 million in 2023, then surged by 93.14% to -$9.0 million in 2024, then surged by 247.35% to $13.2 million in 2025, then sank by 150.26% to -$6.6 million in 2026.
- Business Quant data shows PROK's Net Cash Flow at -$6.6 million in Q1 2026, $13.2 million in Q4 2025, and $10.4 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 2.44 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 625.70 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -2.44 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 457.40 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 664,983.53 |
| 10 | Prokidney | 259.01 Mn | 1.55 Bn | - | -6.64 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -6.64 Mn |
| Mar 31, 2026 | -6.64 Mn |
| Dec 31, 2025 | 13.21 Mn |
| Dec 31, 2025 | 13.21 Mn |
| Sep 30, 2025 | 10.38 Mn |
| Sep 30, 2025 | 10.38 Mn |
| Jun 30, 2025 | -12.87 Mn |
| Jun 30, 2025 | -12.87 Mn |
| Mar 31, 2025 | -1.32 Mn |
| Mar 31, 2025 | -1.32 Mn |
| Dec 31, 2024 | -8.97 Mn |
| Dec 31, 2024 | -8.97 Mn |
| Sep 30, 2024 | -106.42 Mn |
| Sep 30, 2024 | -106.42 Mn |
| Jun 30, 2024 | 130.12 Mn |
| Jun 30, 2024 | 130.12 Mn |
| Mar 31, 2024 | 23.74 Mn |
| Mar 31, 2024 | 23.74 Mn |
| Dec 31, 2023 | -130.74 Mn |
| Dec 31, 2023 | -130.74 Mn |